Study protocol: a multicentre, prospective, phase II trial of isotoxic hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer

by Qiang Lin, Yue-E Liu, Xiao-Ying Xue, Xue-Ji Chen, Yu-Xia Ding, Chao-Xing Liu, Yue-Liang Qin, Wei-Qian Li, Xiao-Cang Ren
Published 2020-10-01